Allogene Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.6M | 761k | 2.13 |
| 2024-09-30 | $959k | 343k | 2.80 |
| 2024-06-30 | $396k | 170k | 2.33 |
| 2024-03-31 | $700k | 157k | 4.47 |
| 2023-12-31 | $594k | 185k | 3.21 |
| 2023-09-30 | $2.5M | 787k | 3.17 |
| 2023-06-30 | $3.3M | 669k | 4.97 |
| 2023-03-31 | $2.5M | 501k | 4.94 |
| 2022-12-31 | $2.7M | 423k | 6.29 |
| 2022-09-30 | $3.4M | 318k | 10.80 |
| 2022-06-30 | $350k | 31k | 11.41 |
| 2022-03-31 | $951k | 104k | 9.11 |
| 2021-12-31 | $1.5M | 100k | 14.92 |
| 2021-09-30 | $1.1M | 44k | 25.69 |
| 2021-06-30 | $2.5M | 96k | 26.09 |
| 2021-03-31 | $4.6M | 130k | 35.29 |
| 2020-12-31 | $1.6M | 61k | 25.26 |
| 2020-09-30 | $3.0M | 79k | 37.72 |
| 2020-06-30 | $3.8M | 89k | 42.82 |
| 2020-03-31 | $1.2M | 62k | 19.43 |
| 2019-12-31 | $1.2M | 48k | 25.97 |
| 2019-09-30 | $870k | 32k | 27.28 |
| 2019-06-30 | $671k | 25k | 26.83 |
| 2019-03-31 | $868k | 30k | 28.92 |
| 2018-12-31 | $27k | 984 | 27.03 |